Neurocrine Biosciences to Present Data on Treatment Patterns and Unmet Needs in Adult and Pediatric Patients Living with Classic Congenital Adrenal Hyperplasia at AMCP 2022
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data on treatment patterns and unmet needs in adult and...
United States Eiryw Roberts Neurocrine Biosciences Academy Of Managed Care Pharmacy Drug Administration Prnewswire Neurocrine Biosciences Inc
Source: prnewswire.com